94 related articles for article (PubMed ID: 32870145)
1. Cancer surveillance imaging: Does repeated iodinated contrast exposure impact long-term kidney function?
Heinen J; Hsu M; Selby LV; Russo AE; Nash GM; Jaimes EA; Shingarev R
Clin Nephrol; 2020 Dec; 94(6):281-289. PubMed ID: 32870145
[TBL] [Abstract][Full Text] [Related]
2. Contrast-induced nephropathy in patients undergoing intravenous contrast-enhanced computed tomography in Korea: a multi-institutional study in 101487 patients.
Lee J; Cho JY; Lee HJ; Jeong YY; Kim CK; Park BK; Sung DJ; Kang BC; Jung SI; Lee EJ; Yi BH; Park SJ; Kim JC; Jung DC; Sung CK; Kim Y; Lee Y; Kim SH; Yoon SK; Park BJ; Kim SH; ;
Korean J Radiol; 2014; 15(4):456-63. PubMed ID: 25053905
[TBL] [Abstract][Full Text] [Related]
3. Influence of Clinical Factors on Risk of Contrast-Induced Nephrotoxicity From IV Iodinated Low-Osmolality Contrast Material in Patients With a Low Estimated Glomerular Filtration Rate.
Ellis JH; Khalatbari S; Yosef M; Cohan RH; Davenport MS
AJR Am J Roentgenol; 2019 Nov; 213(5):W188-W193. PubMed ID: 31268731
[No Abstract] [Full Text] [Related]
4. Prediction of presence of kidney disease in patients undergoing intravenous iodinated contrast enhanced computed tomography: a validation study.
Schreuder SM; Stoker J; Bipat S
Eur Radiol; 2017 Apr; 27(4):1613-1621. PubMed ID: 27436026
[TBL] [Abstract][Full Text] [Related]
5. Prediction of presence of kidney disease in a general patient population undergoing intravenous iodinated contrast enhanced computed tomography.
Moos SI; Stoker J; Nagan G; de Weijert RS; van Vemde DN; Bipat S
Eur Radiol; 2014 Jun; 24(6):1266-75. PubMed ID: 24663822
[TBL] [Abstract][Full Text] [Related]
6. Probability of reduced renal function after contrast-enhanced CT: a model based on serum creatinine level, patient age, and estimated glomerular filtration rate.
Herts BR; Schneider E; Obuchowski N; Poggio E; Jain A; Baker ME
AJR Am J Roentgenol; 2009 Aug; 193(2):494-500. PubMed ID: 19620448
[TBL] [Abstract][Full Text] [Related]
7. Incidence of contrast-induced acute kidney injury (CI-AKI) in high-risk oncology patients undergoing contrast-enhanced CT with a reduced dose of the iso-osmolar iodinated contrast medium iodixanol.
Werner S; Bez C; Hinterleitner C; Horger M
PLoS One; 2020; 15(5):e0233433. PubMed ID: 32437415
[TBL] [Abstract][Full Text] [Related]
8. Administration of iodinated contrast: What is the risk in cancer patients?
González Cervantes JJ; Mascarós Martínez JM; Arana E
Eur J Cancer Care (Engl); 2021 Jan; 30(1):e13351. PubMed ID: 33135211
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness of a practical protocol for the prevention of contrast-induced nephropathy: improved prevention of contrast-induced nephropathy].
Yamaguchi Y; Morita M; Mega A; Haga R; Nagayama I; Yamanouchi Y; Oka T; Nagatoya K; Yamauchi A
Nihon Jinzo Gakkai Shi; 2016; 58(4):587-95. PubMed ID: 27416703
[TBL] [Abstract][Full Text] [Related]
10. Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate.
McDonald JS; McDonald RJ; Carter RE; Katzberg RW; Kallmes DF; Williamson EE
Radiology; 2014 Apr; 271(1):65-73. PubMed ID: 24475854
[TBL] [Abstract][Full Text] [Related]
11. Renal assessment using CKD-EPI equation is useful as an early predictor of contrast- induced nephropathy in elderly patients with cancer.
Park SY; Lee KW
J Geriatr Oncol; 2017 Jan; 8(1):44-49. PubMed ID: 27491499
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Safety Guidelines on the Use of Iodinated Contrast Material: Conundrum Continued.
Nijssen EC; Nelemans PJ; Rennenberg RJ; van Ommen V; Wildberger JE
Invest Radiol; 2018 Oct; 53(10):616-622. PubMed ID: 29762257
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of patient questionnaire in predicting renal dysfunction in outpatients older than 60 years of age prior to contrast-enhanced computed tomography.
Lui EH; Lau KK; Polkinghorne K; Chang CA; Ardley N
J Med Imaging Radiat Oncol; 2012 Apr; 56(2):168-72. PubMed ID: 22498189
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of risk factors for contrast-induced nephrotoxicity in outpatients undergoing intravenous contrast-enhanced computed tomography studies.
Carstensen M; Keer D; Rempel J; Jeon P; Barrett B
Can Assoc Radiol J; 2012 Aug; 63(3):177-82. PubMed ID: 22030305
[TBL] [Abstract][Full Text] [Related]
15. Effect of IV contrast medium on renal function in oncologic patients undergoing CT in ICU.
Ng CS; Shaw AD; Bell CS; Samuels JA
AJR Am J Roentgenol; 2010 Aug; 195(2):414-22. PubMed ID: 20651198
[TBL] [Abstract][Full Text] [Related]
16. Long-term effect of lithium maintenance therapy on estimated glomerular filtration rate in patients with affective disorders: a population-based cohort study.
Clos S; Rauchhaus P; Severn A; Cochrane L; Donnan PT
Lancet Psychiatry; 2015 Dec; 2(12):1075-83. PubMed ID: 26453408
[TBL] [Abstract][Full Text] [Related]
17. Risk of renal events following intravenous iodinated contrast material administration among inpatients admitted with cancer a retrospective hospital claims analysis.
Ng CS; Kalva SP; Gunnarsson C; Ryan MP; Baker ER; Mehta RL
Cancer Imaging; 2018 Aug; 18(1):30. PubMed ID: 30143056
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Split Renal Function Using a Combination of Contrast-Enhanced CT and Serum Creatinine Values for Glomerular Filtration Rate Estimation.
Shi W; Liang X; Wu N; Zhang H; Yuan X; Tan Y
AJR Am J Roentgenol; 2020 Jul; 215(1):142-147. PubMed ID: 32255686
[No Abstract] [Full Text] [Related]
19. Iodixanol versus iopromide in cancer patients: Evidence from a randomized clinical trial.
Terrenato I; Sperati F; Musicco F; Pozzi AF; di Turi A; Caterino M; de Lutio di Castelguidone E; Setola SV; Bellomi M; Neumaier CE; Conti L; Cigliana G; Merola R; Antenucci A; Orlandi G; Giordano A; Barba M; Canitano S
J Cell Physiol; 2018 Mar; 233(3):2572-2580. PubMed ID: 28777459
[TBL] [Abstract][Full Text] [Related]
20. Contrast safety in the cancer patient: preventing contrast-induced nephropathy.
Heiken JP
Cancer Imaging; 2008 Oct; 8 Spec No A(Spec Iss A):S124-7. PubMed ID: 18852085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
